In Vitro Antioxidant and In Silico Evaluation of the Anti-β-Lactamase Potential of the Extracts of

Albert O Ikhane, Siphesihle Z Sithole, Nkosinathi D Cele, Foluso O Osunsanmi, Rebamang A Mosa, Andrew R Opoku

Abstract read

In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Integrated bioactivity assessment of the cyanobacterium plectonema terebrans extract: an in vitro and in silico study.Antonie van Leeuwenhoek · 2026
Article
Antibacterial Potential of Crude Extracts fromMicroorganisms · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Albert O IkhaneDepartment of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa.ORCID 0000-0003-1333-6374

Siphesihle Z SitholeDepartment of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa.ORCID 0000-0002-5387-0814

Nkosinathi D CeleDepartment of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa.

Foluso O OsunsanmiDepartment of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa.

Rebamang A MosaDepartment of Biochemistry, Genetics and Microbiology, University of Pretoria, Hatfield 0028, South Africa.ORCID 0000-0002-7189-2822

Andrew R OpokuDepartment of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyanobacteria in recent times have been touted to be a suitable source for the discovery of novel compounds, including antioxidants and antibiotics, due to their large arsenal of metabolites. This study presents the in vitro antioxidant and in silico evaluation of

Indexed as

antioxidantscyanobacteriaGC-MSmolecular dockingβ-lactamase

Identifiers

PMID38790713

DOI10.3390/antiox13050608

PMCPMC11117491

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.